Platelet-derived growth factor isoforms decrease insulin-like growth factor I gene expression in rat vascular smooth muscle cells and selectively stimulate the biosynthesis of insulin-like growth factor binding protein 4.
- 1 September 1992
- journal article
- abstracts
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 71 (3) , 646-656
- https://doi.org/10.1161/01.res.71.3.646
Abstract
Platelet-derived growth factor (PDGF) is believed to be a critical mediator of vascular smooth muscle cell (SMC) proliferation. Because insulin-like growth factor (IGF) I (IGF-I) functions as a progression factor for the mitogenic effects of PDGF, we hypothesized that IGF-I gene expression and the production of IGF binding proteins (IGFBPs) by cultured rat aortic SMCs might be regulated by one or more of the three isoforms of PDGF: PDGF-AA, -BB, and -AB. IGF-I gene expression was highly dependent on cell density: IGF-I mRNA transcripts decreased markedly as a function of cell confluence. IGF-I mRNA content was inhibited to a similar degree by PDGF-AA, -BB, and -AB through a mechanism requiring protein synthesis. The inhibition was readily apparent at 4 hours, reaching approximately 25% of control levels after 24 hours. Radioimmunoassayable IGF-I was only barely detectable in SMC-conditioned serum-free medium and not significantly modulated by PDGF. Western ligand blot revealed that vascular SMCs release 30-kd and 24-kd IGFBP into serum-free conditioned medium. PDGF isoforms did not significantly alter release of the 30-kd IGFBP but evoked a fivefold to sixfold increase in the 24-kd IGFBP. The 24-kd IGFBP was found to comigrate with IGFBP-4, a recently identified binding protein that inhibits IGF action. The 30-kd protein was not merely a glycosylated form of IGFBP-4, because it was not sensitive to N-glycanase digestion. PDGF-AA, -BB, and -AB markedly induced expression of IGFBP-4 mRNA in a time- and concentration-dependent fashion. Vascular SMCs also express IGFBP-2 mRNA, but its abundance was not induced by PDGF. In conclusion, PDGF evokes a complex pattern of regulation of genes in the IGF/IGFBP system. By inhibiting IGF-I production and specifically inducing biosynthesis of the inhibitory binding protein IGFBP-4, PDGF may set in motion mechanisms to limit the final magnitude of the mitogenic response.Keywords
This publication has 44 references indexed in Scilit:
- Regulation of insulin-like growth factor I messenger RNA levels in vascular smooth muscle cells.Hypertension, 1991
- PDGF ligand and receptor gene expression during repair of arterial injury.The Journal of cell biology, 1990
- Molecular Localization of the Transforming and Secretory Properties of PDGF A and PDGF BScience, 1990
- Regulation of insulin-like growth factor-I gene expression by growth factors in cultured vascular smooth muscle cellsJournal of Endocrinology, 1990
- Differential effects of the various isoforms of platelet-derived growth factor on chemotaxis of fibroblasts, monocytes, and granulocytes.Journal of Clinical Investigation, 1990
- Complementary DNA structure of the high molecular weight rat insulin-like growth factor binding protein (IGF-BP3) and tissue distribution of its mRNABiochemical and Biophysical Research Communications, 1989
- Insulin-like growth factor binding proteins from cultured human fibroblasts. Characterization and hormonal regulation.Journal of Clinical Investigation, 1989
- Binding proteins for the insulin-like growth factors: Structure, regulation and functionProgress in Growth Factor Research, 1989
- The biology of platelet-derived growth factorCell, 1986
- Epidermal growth factor (EGF) is required only during the traverse of early G1 in PDGF stimulated density-arrested BALB/c-3T3 cellsExperimental Cell Research, 1983